Frederick Schnure
Gastroenterology · Fall River, MANPI 1881688232
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $965 and has fallen 95.2% since, to $47 in 2025.
Across 101 payments — averaging $15.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$329
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$232
- Johnson & Johnson$215
- Takeda Pharmaceuticals U.S.A., Inc.$200
- Pfizer$169
- Merck$134
- plus $241 from 9 others
Across 21 payments — averaging $5243.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$101K
- Boehringer Ingelheim$6K
- Boehringer Ingelheim RCV GmbH & Co KG$2K
- Eli Lilly$1K
What the payments were for
- Food & beverage$1,521100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 17 | $329 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $232 |
| Johnson & Johnson | 15 | $215 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $200 |
| Pfizer | 13 | $169 |
| Merck | 9 | $134 |
| Ironwood Pharmaceuticals, Inc | 4 | $71 |
| UCB, Inc. | 3 | $57 |
| Amgen | 1 | $24 |
| Alfasigma USA, Inc. | 1 | $18 |
| QOL Medical, LLC | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Romark Laboratories, LC | 1 | $14 |
| Gilead | 1 | $12 |
| Shire North American Group Inc | 1 | $12 |
How this compares
$1,521 in reported general payments places this provider in the 55th percentile of 579 gastroenterology providers in Massachusetts.
Other gastroenterology in Fall River
- Thomas CapozzaFall River$44K
- Hiroyuki AiharaBoston$728K
- Jessica AllegrettiBoston$696K
- John LeungBoston$682K
- Ramnik XavierBoston$567K
- Adam CheifetzBoston$512K
- Carlo TraversoBoston$447K
- Razvan ArsenescuMedford$385K
- Steven FineFramingham$259K
- Tyler BerzinBoston$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.